QA: Urovant Sciences Ltd. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001740547_2020_Urovant_Sciences_Ltd.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001740547')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001740547, Urovant Sciences Ltd.

  xvar xval
0 AssetsCurrent 98,510,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 923,000
3 remainder_Assets 688,000
4 LiabilitiesCurrent 11,817,000
5 LiabilitiesNoncurrent 13,534,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,585,000
9 ResearchAndDevelopmentExpense 92,198,000
10 remainder_Expenses 304,000
11 remainder_Revenues 0
12 remainder_NetIncome -259,000
13 remainder_ComprehensiveNetIncome 262,000
  yvar yval
0 Assets 100,121,000
1 Liabilities 25,351,000
2 Expenses 111,087,000
3 Revenues 0
4 StockholdersEquity 74,770,000
5 NetIncome -111,346,000
6 ComprehensiveNetIncome -111,215,000
7 BaseVar 118,540,000
8 EconomicCapitalRatio 0.277

Edgar->Model Mapping

Feature Distribution

Change over Time